Clinical trial
Analysis of the Effects Derived from the Use of Microporous Polysaccharide Hemospheres in Mastectomies with or Without Associated Lymphadenectomy
NCT06824831 is registered in ClinicalTrials.gov with Fundación para la Investigación del Hospital Clínico de Valencia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of the Effects Derived from the Use of Microporous Polysaccharide Hemospheres in Mastectomies with or Without Associated Lymphadenectomy
- Lead sponsor
- Fundación para la Investigación del Hospital Clínico de Valencia
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 1, 2020
- Completion date
- September 2, 2024
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast neoplasm malignant female, breast surgery, lymphadenectomy, mastectomy, seroma following procedure